EdgarLookup

Palomar Holdings, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Palomar Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
22.5%
Profit Margin
Net income ÷ revenue
6.5%
Return on Assets
Net income ÷ assets
2.24x
Debt-to-Equity
Total liabilities ÷ equity
+58.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $875.97M Feb 24, 2026
FY2025 Dec 31, 2024 $553.86M Feb 24, 2026
FY2025 Dec 31, 2023 $375.93M Feb 24, 2026
FY2024 Dec 31, 2022 $327.09M Feb 25, 2025
FY2023 Dec 31, 2021 $247.79M Feb 23, 2024
FY2020 Dec 31, 2020 $42.30M Mar 9, 2021
FY2020 Sep 30, 2020 $45.00M Mar 9, 2021
FY2020 Jun 30, 2020 $43.15M Mar 9, 2021
FY2020 Mar 31, 2020 $38.02M Mar 9, 2021
FY2020 Dec 31, 2019 $34.62M Mar 9, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $197.07M Feb 24, 2026
FY2025 Dec 31, 2024 $117.57M Feb 24, 2026
FY2025 Dec 31, 2023 $79.20M Feb 24, 2026
FY2024 Dec 31, 2022 $52.17M Feb 25, 2025
FY2023 Dec 31, 2021 $45.85M Feb 23, 2024
FY2020 Dec 31, 2020 ($1.85M) Mar 9, 2021
FY2020 Sep 30, 2020 ($15.68M) Mar 9, 2021
FY2020 Jun 30, 2020 $12.01M Mar 9, 2021
FY2020 Mar 31, 2020 $11.78M Mar 9, 2021
FY2020 Dec 31, 2019 $10.88M Mar 9, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $409.12M Feb 24, 2026
FY2025 Dec 31, 2024 $261.16M Feb 24, 2026
FY2025 Dec 31, 2023 $116.11M Feb 24, 2026
FY2024 Dec 31, 2022 $169.58M Feb 25, 2025
FY2023 Dec 31, 2021 $87.81M Feb 23, 2024
FY2022 Dec 31, 2020 $57.49M Mar 1, 2023
FY2021 Dec 31, 2019 $44.51M Feb 25, 2022
FY2020 Dec 31, 2018 $22.81M Mar 9, 2021
FY2019 Dec 31, 2017 $20.25M Feb 28, 2020

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $137.0K Feb 24, 2026
FY2025 Dec 31, 2024 $243.0K Feb 24, 2026
FY2025 Dec 31, 2023 $15.0K Feb 24, 2026
FY2024 Dec 31, 2022 $313.0K Feb 25, 2025
FY2023 Dec 31, 2021 $18.0K Feb 23, 2024
FY2022 Dec 31, 2020 $132.0K Mar 1, 2023
FY2021 Dec 31, 2019 $115.0K Feb 25, 2022
FY2020 Dec 31, 2018 $332.0K Mar 9, 2021
FY2019 Dec 31, 2017 $68.0K Feb 28, 2020

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.05B Feb 24, 2026
FY2025 Dec 31, 2024 $2.26B Feb 24, 2026
FY2024 Dec 31, 2023 $1.71B Feb 25, 2025
FY2023 Dec 31, 2022 $1.31B Feb 23, 2024
FY2022 Dec 31, 2021 $925.73M Mar 1, 2023
FY2021 Dec 31, 2020 $729.09M Feb 25, 2022
FY2020 Dec 31, 2019 $395.46M Mar 9, 2021
FY2019 Dec 31, 2018 $231.13M Feb 28, 2020

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.11B Feb 24, 2026
FY2025 Dec 31, 2024 $1.53B Feb 24, 2026
FY2024 Dec 31, 2023 $1.24B Feb 25, 2025
FY2023 Dec 31, 2022 $921.70M Feb 23, 2024
FY2022 Dec 31, 2021 $531.57M Mar 1, 2023
FY2021 Dec 31, 2020 $365.38M Feb 25, 2022
FY2020 Dec 31, 2019 $176.91M Mar 9, 2021
FY2019 Dec 31, 2018 $134.84M Feb 28, 2020

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $942.67M Feb 24, 2026
FY2025 Dec 31, 2024 $729.03M Feb 24, 2026
FY2025 Dec 31, 2023 $471.25M Feb 24, 2026
FY2025 Dec 31, 2022 $384.75M Feb 24, 2026
FY2022 Dec 31, 2021 $394.17M Mar 1, 2023
FY2021 Dec 31, 2020 $363.71M Feb 25, 2022
FY2021 Dec 31, 2019 $218.56M Feb 25, 2022
FY2021 Dec 31, 2018 $96.29M Feb 25, 2022
FY2020 Dec 31, 2017 $78.41M Mar 9, 2021
FY2019 Dec 31, 2016 $73.11M Feb 28, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $30.47M Feb 24, 2026
FY2025 Dec 31, 2024 $3.76M Feb 24, 2026
FY2024 Dec 31, 2023 $3.76M Feb 25, 2025
FY2023 Dec 31, 2022 $0 Feb 23, 2024

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $422.00M Feb 24, 2026
FY2025 Dec 31, 2024 $262.22M Feb 24, 2026
FY2024 Dec 31, 2023 $144.64M Feb 25, 2025
FY2023 Dec 31, 2022 $87.71M Feb 23, 2024
FY2022 Dec 31, 2021 $69.95M Mar 1, 2023
FY2021 Dec 31, 2020 $39.96M Feb 25, 2022
FY2020 Dec 31, 2019 $33.86M Mar 9, 2021
FY2019 Dec 31, 2018 $28.36M Feb 28, 2020
FY2019 Jan 1, 2018 $3.20M Feb 28, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $106.88M Feb 24, 2026
FY2025 Dec 31, 2024 $80.44M Feb 24, 2026
FY2024 Dec 31, 2023 $51.55M Feb 25, 2025
FY2023 Dec 31, 2022 $68.11M Feb 23, 2024
FY2022 Dec 31, 2021 $50.28M Mar 1, 2023
FY2021 Dec 31, 2020 $33.54M Feb 25, 2022
FY2020 Dec 31, 2019 $33.12M Mar 9, 2021
FY2019 Dec 31, 2018 $9.53M Feb 28, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 24, 2026
FY2025 Dec 31, 2024 4 Feb 24, 2026
FY2025 Dec 31, 2023 3 Feb 24, 2026
FY2024 Dec 31, 2022 2 Feb 25, 2025
FY2023 Dec 31, 2021 1 Feb 23, 2024
FY2020 Dec 31, 2020 0 Mar 9, 2021
FY2020 Sep 30, 2020 0 Mar 9, 2021
FY2020 Jun 30, 2020 0 Mar 9, 2021
FY2020 Mar 31, 2020 0 Mar 9, 2021
FY2020 Dec 31, 2019 0 Mar 9, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 24, 2026
FY2025 Dec 31, 2024 4 Feb 24, 2026
FY2025 Dec 31, 2023 3 Feb 24, 2026
FY2024 Dec 31, 2022 2 Feb 25, 2025
FY2023 Dec 31, 2021 1 Feb 23, 2024
FY2020 Dec 31, 2020 0 Mar 9, 2021
FY2020 Sep 30, 2020 0 Mar 9, 2021
FY2020 Jun 30, 2020 0 Mar 9, 2021
FY2020 Mar 31, 2020 0 Mar 9, 2021
FY2020 Dec 31, 2019 0 Mar 9, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 26.52M Feb 24, 2026
FY2025 Dec 31, 2024 26.53M Feb 24, 2026
FY2024 Dec 31, 2023 24.77M Feb 25, 2025
FY2023 Dec 31, 2022 25.03M Feb 23, 2024
FY2022 Dec 31, 2021 25.43M Mar 1, 2023
FY2021 Dec 31, 2020 25.53M Feb 25, 2022
FY2020 Dec 31, 2019 23.47M Mar 9, 2021
FY2019 Dec 31, 2018 17.00M Feb 28, 2020